Congress | NACDS

NACDS Lauds Senate Finance Committee for Bipartisan Efforts to Deliver Real and Comprehensive PBM Reform that is Meaningful for Patients and Pharmacies Looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs

admin2023-07-27T11:01:36-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Pharmacy_Value, Reimbursement|

NACDS looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs.

National Coalition Applauds Introduction of Senate Legislation to Ensure Senior Access to Prompt Pharmacist Care and Services More Than 190 Organizations Support S. 2447 to Provide Payment for Pharmacist Services for COVID-19, Flu, Strep, and RSV Under Medicare Part B

admin2023-07-26T15:43:52-04:00Categories: Press Release|Tags: Congress, Medicare, Pharmacy_Value, Preparedness, Reimbursement, Vaccinations|

More Than 190 Organizations Support S. 2447 to Provide Payment for Pharmacist Services for COVID-19, Flu, Strep, and RSV Under Medicare Part B.

NACDS to the U.S. Congress: Real PBM Reform Must Include Medicare and Medicaid A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance

admin2023-07-25T09:58:47-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Pharmacy_Value, Reimbursement|

A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance.

NACDS Commends Senate Finance Committee for Scheduling PBM Reform Bill Markup, Pledges Engagement for Real PBM Reform That Addresses Needs of Medicare and Medicaid Patients and Their Pharmacies “S. 1038 and S. 2052 are vital for real PBM reform, and for addressing ‘pharmaceutical benefit manipulation’ that harms the most vulnerable in the Medicaid and Medicare programs.”

admin2023-07-13T15:30:09-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Pharmacy_Value, Reimbursement|

“S. 1038 and S. 2052 are vital for real PBM reform, and for addressing ‘pharmaceutical benefit manipulation’ that harms the most vulnerable in the Medicaid and Medicare programs.”

Momentum Builds in Advancement and Coverage of PBM Reform From industry trade press, to publications serving the broader business community, to media outlets relied on by government decision-makers, important story lines about pharmacy benefit manager reform continue to generate headlines and attention across the nation.

admin2023-06-22T10:22:20-04:00Categories: In Case You Missed It|Tags: Congress, DIR, Medicaid, NACDS, PBM, Reimbursement|

From industry trade press, to publications serving the broader business community, to media outlets relied on by government decision-makers, important story lines about pharmacy benefit manager reform continue to generate headlines and attention across the nation.

NACDS Lauds DIR Fee and Pharmacy Access Bill as Vital for PBM Reform Bill aims to preserve seniors’ freedom of pharmacy choice by confronting tactics that bar pharmacies from Part D networks and drive pharmacies out of business

admin2023-06-21T14:08:59-04:00Categories: Press Release|Tags: Congress, DIR, Medicaid, PBM, Reimbursement|

NACDS today praised the bipartisan introduction of the Protect Patient Access to Pharmacies Act (S. 2052) – a bill that would help preserve Medicare beneficiaries’ access to their pharmacy of choice and help stop “pharmaceutical benefit manipulation” that harms patients and pharmacies alike.

With United Voice, Pharmacy Praises Bipartisan “Pharmacy DIR Reform” and Pharmacy Access Bill Vital for Patients, Medicare, and Pharmacies Bill addresses abusive business practices and supports patients’ access to pharmacies

admin2023-06-21T14:06:58-04:00Categories: Press Release|Tags: Congress, DIR, Medicaid, PBM, Reimbursement|

Organizations representing pharmacists and pharmacies are applauding the Protect Patient Access to Pharmacies Act (S. 2052) introduced on June 21 in the U.S. Senate.

NACDS Praises House Energy and Commerce Committee for Unanimous Passage of PATIENT Act Action is essential component of PBM reform in the Medicaid program and vital for patients and the pharmacies serving them

admin2023-05-25T10:14:57-04:00Categories: Press Release|Tags: Congress, DIR, Medicaid, PBM, Reimbursement|

Action is essential component of PBM reform in the Medicaid program and vital for patients and the pharmacies serving them.

Pharmacy and Pharmacist Groups Emphasize Importance of PBM Reform for Patients and the Pharmacies and Pharmacists That Serve Them Urge Congress to remain focused on bipartisan PBM reform momentum despite attempts of PBM industry to define the issue as a fight with pharmaceutical manufacturers

admin2023-05-23T17:04:00-04:00Categories: Press Release|Tags: Congress, DIR, Medicaid, PBM, Reimbursement|

Organizations commend House Committee on Oversight and Accountability for hearing on PBM tactics.

NACDS Lauds House Energy and Commerce Committee for Inclusion of NACDS-Backed PBM Reform Bill in PATIENT Act Says this action is essential component of PBM reform in the Medicaid program and vital for patients and the pharmacies serving them

admin2023-05-23T14:49:33-04:00Categories: Press Release|Tags: Congress, DIR, Medicaid, PBM, Reimbursement|

NACDS President and CEO Steven C. Anderson released the following statement today in anticipation of a legislative markup on May 24 by the U.S. House of Representatives Committee on Energy and Commerce:

National Association of Chain Drug StoresPharmacies. The face of neighborhood healthcare.